Let's Talk... SMA at WMS 2022

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Oct 14 / Springer Healthcare

Let's Talk... SMA at WMS 2022

Neuroscience Spinal Muscular Atrophy WMS-2022

Description

In this episode, we speak to Laurent Servais about biomarker research in spinal muscular atrophy, discussing several abstracts presented at the WMS 2022 congress that demonstrated the potential of various microRNAs and proteins that may warrant further investigation.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.